TrialJournal of Korean medical science2022

A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.

Hyung Joon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.